NSAID (Piroxicam)‐accelerated IBD in IL‐10−/− mice highly resembles human IBD in terms of heterogeneous pathogenesis and impaired epithelial integrity in disease development (Holgersen et al. This evidence concerns the gene IL10 and inflammatory bowel disease.